Lei Lei

Title: Lei Lei: Innovator in Cancer Treatment

Introduction

Lei Lei is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of cancer treatment through his innovative research and patented technologies. His work focuses on enhancing macrophage-mediated antibody-guided cancer cell or tumor eradication.

Latest Patents

Lei Lei holds a patent for "Compositions and methods for enhancing macrophage-mediated antibody guided cancer cell or tumor eradication." This patent includes Shp2- and Spleen tyrosine kinase (Syk)-integrated sensing and actuating protein (iSNAP) chimeric proteins. These proteins comprise a bi-phosphorylatable peptide, a bisphosphoryl tyrosine-based activation (BTAM) motif, and a Fluorescent Protein (FP) Förster Resonance Energy Transfer (FRET) pair. The invention also features engineered cells and methods aimed at cancer cell or tumor eradication, promoting an anti-cancer inflammatory response, and enhancing various immune cell-mediated responses.

Career Highlights

Lei Lei is affiliated with the University of California, where he continues to advance his research in cancer therapies. His innovative approaches have garnered attention in the scientific community, contributing to the development of new treatment methodologies.

Collaborations

Lei Lei has collaborated with notable researchers, including Yingxiao Wang and Shu Chien. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work.

Conclusion

In summary, Lei Lei is a dedicated inventor whose work in cancer treatment exemplifies the potential of innovative research to improve patient outcomes. His patented technologies represent a significant advancement in the fight against cancer.